Jain Global »

Summit Therapeutics shares owned by Jain Global

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Jain Global from 13F filings

Historical chart of Jain Global investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Jain Global consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Jain Global

Quarter filed Position value Share count Share price at filing
2026-03-31 $205k 11k 18.96
2025-06-30 $1.9M 88k 21.28

More positions owned by Jain Global

Spdr Gold Tr Gold Shs (GLD)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr Russell 2000 Etf (IWM)
Vaneck Etf Trust Gold Miners Etf (GDX)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Meta Platforms Cl A (META)
Spdr Series Trust State Street Spd (KRE)
Boeing Company (BA)
Select Sector Spdr Tr State Street Ene (XLE)
Micron Technology (MU)
Kraneshares Trust Csi Chi Internet (KWEB)
Select Sector Spdr Tr State Street Fin (XLF)
Apple (AAPL)

View all positions for Jain Global

Top funds holding Summit Therapeutics

Baker Bros. Advisors
FMR
Vanguard Group
BlackRock
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
UBS Group
Geode Capital Management
Susquehanna International
D. E. Shaw & Co
Morgan Stanley
Pictet Asset Management Holding SA
Apeiron Capital
Citadel Advisors

View all funds holding Summit Therapeutics